Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornel Popovici

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|October 21, 2003
Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancerChristophe Ginestier, Valérie-Jeanne Bardou, Cornel Popovici, et al.
Familial Cancer|February 3, 2016
Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosisRenaud Sabatier, Elise Lavit, Jessica Moretta, et al.
American Journal of Medical Genetics. Part A|May 13, 2014
Intragenic rearrangements in X-linked intellectual deficiency: results of a-CGH in a series of 54 patients and identification of TRPC5 and KLHL15 as potential XLID genesCécile Mignon-Ravix, Pierre Cacciagli, Nancy Choucair, et al.
American Journal of Medical Genetics. Part A|June 26, 2010
Syndromic mental retardation with thrombocytopenia due to 21q22.11q22.12 deletion: Report of three patientsEleni Katzaki, Gilles Morin, Marzia Pollazzon, et al.
The American Journal of Surgical Pathology|December 2, 2017
CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell TumorsLuc Xerri, José Adélaïde, Cornel Popovici, et al.
International Journal of Oncology|May 5, 2005
Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusionAnne Murati, Christine Arnoulet, Marina Lafage-Pochitaloff, et al.
Experimental Dermatology|October 15, 2014
Characterization of the novel Sezary lymphoma cell line BKP1John Boudjarane, Arnaud Essaydi, Laure Farnault, et al.
Genes, Chromosomes & Cancer|September 28, 2002
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT geneCornel Popovici, Céline Basset, François Bertucci, et al.
Genes, Chromosomes & Cancer|June 12, 2003
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 geneJosé Adélaïde, Huai-En Huang, Anne Murati, et al.
BMC Cancer|May 4, 2007
Nectin-4 is a new histological and serological tumor associated marker for breast cancerStéphanie Fabre-Lafay, Florence Monville, Sarah Garrido-Urbani, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|October 21, 2003
Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancerChristophe Ginestier, Valérie-Jeanne Bardou, Cornel Popovici, et al.
Familial Cancer|February 3, 2016
Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosisRenaud Sabatier, Elise Lavit, Jessica Moretta, et al.
American Journal of Medical Genetics. Part A|May 13, 2014
Intragenic rearrangements in X-linked intellectual deficiency: results of a-CGH in a series of 54 patients and identification of TRPC5 and KLHL15 as potential XLID genesCécile Mignon-Ravix, Pierre Cacciagli, Nancy Choucair, et al.
American Journal of Medical Genetics. Part A|June 26, 2010
Syndromic mental retardation with thrombocytopenia due to 21q22.11q22.12 deletion: Report of three patientsEleni Katzaki, Gilles Morin, Marzia Pollazzon, et al.
The American Journal of Surgical Pathology|December 2, 2017
CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell TumorsLuc Xerri, José Adélaïde, Cornel Popovici, et al.
International Journal of Oncology|May 5, 2005
Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusionAnne Murati, Christine Arnoulet, Marina Lafage-Pochitaloff, et al.
Experimental Dermatology|October 15, 2014
Characterization of the novel Sezary lymphoma cell line BKP1John Boudjarane, Arnaud Essaydi, Laure Farnault, et al.
Genes, Chromosomes & Cancer|September 28, 2002
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT geneCornel Popovici, Céline Basset, François Bertucci, et al.
Genes, Chromosomes & Cancer|June 12, 2003
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 geneJosé Adélaïde, Huai-En Huang, Anne Murati, et al.
BMC Cancer|May 4, 2007
Nectin-4 is a new histological and serological tumor associated marker for breast cancerStéphanie Fabre-Lafay, Florence Monville, Sarah Garrido-Urbani, et al.
Pageof 6